The Company is pleased to announce the establishment of an Investment Committee (the 鈥淐ommittee鈥�) of the Board. The Committee, established on 24th January 2025, will reinforce the Company鈥檚 investment strategies and capital allocation.
The Board recognises the need for the Company to remain agile in uncertain markets and adapt its investment strategy and capital allocation as needed, alongside identifying initiatives to accelerate and deliver cash generation and enhanced returns on capital. The Committee will provide additional oversight to these areas in line with the Company鈥檚 commitment to delivering sustainable shareholder value.
Specific responsibilities of the Committee will include review and endorsement of i) investment and capital allocation strategy, ii) major capital projects and, iii) M&A activity. In discharging these duties, the Committee will give consideration to leading market indicators, execution risk, and levels of return and cash generation for shareholders.
The Committee will be chaired by Barbara Jeremiah, Senior Independent Director and will initially consist of the following additional members:
Liam Condon: Chief Executive
Sinead Lynch: Independent Non-Executive Director
Stephen Oxley: Chief Financial Officer
Doug Webb: Independent Non-Executive Director
The Committee鈥檚 Terms of Reference will shortly be available on our website:
This announcement is made in compliance with the Company鈥檚 obligations under the UK Listing Rules (鈥淯KLR鈥�), specifically UKLR 6.4.6R.
Enquiries:
Simon Price: General Counsel and Company Secretary, +44 20 7269 8052
Martin Dunwoodie: Director of Investor Relations and Treasury, +44 20 7269 8241